From the 2020 Joint Annual Meeting (June 29, 2020)
Presented by Tiffany Roberts, PhD
From name confirmation by phlebotomists, to sex-specific reference intervals, the lab interacts with the healthcare of transgender patients in important ways. With more transgender patients presenting for clinical management, and more clinicians armed with hormone therapy guidelines created and endorsed by the Endocrine Society, it will be expected for laboratory professionals to know how to manage these patients. This session will focus on what comprises a normal laboratory result for a transgender patient.
At the conclusion of this presentation, participants will be able to:
- Describe the difference between sex and gender.
- Summarize the implications that sex vs gender linkage may have for the clinical laboratory.
- Identify analytes that may be affected by hormone therapy in transgender individuals.
This recorded presentation is P.A.C.E. ® accredited. The instruction level for this activity is Intermediate. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the area of General will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.
LEVEL OF INSTRUCTION
This intermediate-level program is appropriate for laboratory professionals working in clinical, public health and academic settings.